GSK2862277 is a human monoclonal antibody (mAb) targeting TNFRSF1A. It enhances the formation of neutrophil extracellular traps and boosts the phagocytic activity of alveolar macrophages. GSK2862277 is applicable for research in acute lung injury and acute respiratory distress syndrome (ARDS). Recommended isotype control: VHH-hFc.
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted
